News tagged with 'Bapineuzumab'

With promises of developing a blockbuster drug to treat 26 million Alzheimer's patients worldwide, research continues on bapineuzumab despite evidence it is not effective and may be targeting the wrong underlying cause of Alzheimer's.

Harvard Medical School researchers have found four new areas that affect the risk of Alzheimer’s disease. They say the findings may eventually help pave the way to new Alzheimer’s treatment options.